FSMDX
Price
$35.98
Change
+$0.22 (+0.62%)
Updated
Jul 3 closing price
Net Assets
42.38B
GMXRX
Price
$15.76
Change
+$0.10 (+0.64%)
Updated
Jul 3 closing price
Net Assets
540.35M
Interact to see
Advertisement

FSMDX vs GMXRX

Header iconFSMDX vs GMXRX Comparison
Open Charts FSMDX vs GMXRXBanner chart's image
Fidelity Mid Cap Index
Price$35.98
Change+$0.22 (+0.62%)
VolumeN/A
Net Assets42.38B
Nationwide Mid Cap Market Idx R
Price$15.76
Change+$0.10 (+0.64%)
VolumeN/A
Net Assets540.35M
FSMDX vs GMXRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMDX vs. GMXRX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and GMXRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 42.4B vs. GMXRX (540M). FSMDX pays higher dividends than GMXRX: FSMDX (1.31) vs GMXRX (0.77). FSMDX was incepted earlier than GMXRX: FSMDX (14 years) vs GMXRX (18 years). GMXRX (1.01) is less costly to investors than FSMDX (0.03). GMXRX is a more actively managed with annual turnover of: 17.74 vs. FSMDX (8.00). FSMDX (0) and GMXRX (0) have matching initial minimum investment requirements. FSMDX annual gain was more profitable for investors over the last year : 15.74 vs. GMXRX (-1.64). FSMDX return over 5 years is better than : 77.61 vs. GMXRX (24.39).
FSMDXGMXRXFSMDX / GMXRX
Total Expense Ratio0.031.003%
Annual Report Gross Expense Ratio0.031.012%
Fund Existence14 years18 years-
Gain YTD6.1491.895324%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets42.4B540M7,852%
Annual Yield % from dividends1.310.77170%
Returns for 1 year15.74-1.64-960%
Returns for 3 years47.5310.05473%
Returns for 5 years77.6124.39318%
Returns for 10 years122.19-13.19-926%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANRO2.350.05
+2.17%
Alto Neuroscience
NYMTL21.51N/A
N/A
New York Mortgage Trust
ARMK42.79-0.19
-0.44%
ARAMARK
SWBI8.90-0.04
-0.45%
Smith & Wesson Brands
WERN29.07-0.18
-0.62%
Werner Enterprises